Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome
Acute respiratory distress syndrome (ARDS) is a multifaced disease characterized by the acute onset of hypoxemia, worsened pulmonary compliance, and noncardiogenic pulmonary edema. Despite over five decades of research, specific treatments for established ARDS are still lacking. MSC-based therapies...
Saved in:
Main Authors: | Jibin Han, Yanmin Li, Yuanyuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2019/5432134 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shock Wave Therapy Enhances Mitochondrial Delivery into Target Cells and Protects against Acute Respiratory Distress Syndrome
by: Kun-Chen Lin, et al.
Published: (2018-01-01) -
Sarcoidosis Presenting as Acute Respiratory Distress Syndrome
by: Bilal Haider Lashari, et al.
Published: (2018-01-01) -
Hypoxemic Respiratory Failure from Acute Respiratory Distress Syndrome Secondary to Leptospirosis
by: Shannon M. Fernando, et al.
Published: (2017-01-01) -
Acute Respiratory Distress Syndrome Associated with Tumour Lysis Syndrome in Leukemia
by: Chaim M Bell, et al.
Published: (1997-01-01) -
Effectiveness of Glucocorticoids in Acute Respiratory Distress Syndrome: An Umbrella Review
by: Semagn Mekonnen Abate, et al.
Published: (2021-01-01)